Medscape LIVE EVENT: Changing Neoadjuvant and Adjuvant Paradigms in HER2-Positive Breast Cancer What Surgeons Need to Know

FRIDAY, 16 OCTOBER 2020 | 12:30 – 13:30 CEST

Like Comment

Register here!

LIVE Virtual Symposium

Participants can access this live virtual event on Friday, October 16, 2020, from 12:30 – 13:30 CEST. Join here

Activity Overview

Join our expert faculty as they discuss therapeutic approaches for patients with HER2-positive early breast cancer. The latest evidence and rationale for neoadjuvant and adjuvant treatment strategies will be discussed, as well as optimal application in routine practice. What do surgeons need to know? Please come with your most pressing questions.


Jasmine Walter

Content Editor, Mark Allen Group

305 Contributions
2 Following